Predict your next investment

Venture Capital
springtideinvestments.com

See what CB Insights has to offer

Investments

7

Funds

1

About SpringTide

SpringTide offers a venture health fund that aims to help and invest in healthcare AI companies.

SpringTide Headquarter Location

Cambridge, Massachusetts, 02141,

United States

801-822-2544

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest SpringTide News

Springtide Becomes the Only Three-Year BHCOE Accredited Entity in Connecticut

Dec 7, 2021

Autism Child Development Center Consistently Recognized for Quality ABA Therapy News provided by Share this article Share this article TRUMBULL, Conn., Dec. 7, 2021 /PRNewswire/ -- Springtide Child Development Center has earned the only Three-Year accreditation in Connecticut from Behavioral Health Center of Excellence® (BHCOE®). As the only ABA-specific accreditation, BHCOE's consistent recognition of Springtide provides validity to the efficacy of Springtide's treatment process. Springtide Becomes the Only Three-Year BHCOE Accredited Entity in Connecticut Quickly becoming a leader in the child development industry, Springtide provides evidence-based autism therapies, including ABA therapy, to children aged 2-18 years old. With four existing centers throughout Connecticut and Massachusetts (and more on their way), Springtide's comprehensive, all-day programs focus on occupational therapy, speech therapy, and Applied Behavior Analysis (ABA) therapy. Established in 2015, BHCOE systematically measures and reports on data from the behavior analysis community to assess which agencies meet their stringent accreditation requirements. Meeting BHCOE's standards for three consecutive years reflects Springtide's commitment to quality autism care through ABA therapy. "Earning BHCOE's three-year accreditation is validation that our team, our processes, and our company as a whole follows through on our commitment to help children and their families thrive," said Jia Jia Ye, Chief Executive Officer of Springtide Child Development Center. "Our mission is to deliver personalized, outcomes-oriented care for children with autism. This is proof that we fulfill that promise." ABA therapy – what many experts consider to be the gold standard of treatment for children with autism – is an integral aspect of Springtide's treatment process, emphasizing holistic, multidisciplinary care and a personalized approach. "Our clinicians help children develop the real-world skills that they need to succeed, maximizing their learning potential and helping them reach essential milestones," said Dr. Michael Cameron, Chief Clinical Officer of Springtide Child Development Center. "By focusing on clinically-backed techniques like ABA therapy, we ensure the children in our programs are empowered with every tool they need to succeed." Springtide's ABA program is designed with the two pillars of social skills and academic achievement in mind. Each child's personalized treatment plan is backed by scientific research to ensure the most effective learning experience possible. With centers in Trumbull, Ridgefield, and West Hartford, Conn., in addition to their newest center in Dedham, Mass., Springtide is well-equipped to provide world-class treatment for children with autism. Families can learn more about Springtide and how to enroll their child by visiting www.myspringtide.com . Media Contact:

SpringTide Investments

7 Investments

SpringTide has made 7 investments. Their latest investment was in Prolucent Health as part of their Series A on December 12, 2021.

CBI Logo

SpringTide Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/13/2021

Series A

Prolucent Health

$11.5M

Yes

6

11/16/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

8/31/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

7/15/2020

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

6/5/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/13/2021

11/16/2021

8/31/2021

7/15/2020

6/5/2020

Round

Series A

Series B

Series A

Seed VC - II

Series A

Company

Prolucent Health

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$11.5M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

6

10

10

10

10

SpringTide Fund History

1 Fund History

SpringTide has 1 fund, including SpringTide Ventures Fund I LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/23/2020

SpringTide Ventures Fund I LP

$14.78M

2

Closing Date

12/23/2020

Fund

SpringTide Ventures Fund I LP

Fund Type

Status

Amount

$14.78M

Sources

2

SpringTide Team

2 Team Members

SpringTide has 2 team members, including current Chief Financial Officer, Jason King.

Name

Work History

Title

Status

Austin Walters

Founder

Current

Jason King

Graybella Capital, Lincoln Peak Capital, Castile Ventures, Summit Partners, Deloitte, and Kevin P. Martin & Associates

Chief Financial Officer

Current

Name

Austin Walters

Jason King

Work History

Graybella Capital, Lincoln Peak Capital, Castile Ventures, Summit Partners, Deloitte, and Kevin P. Martin & Associates

Title

Founder

Chief Financial Officer

Status

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.